- ICH GCP
- US Clinical Trials Registry
- Klinisk utprøving NCT07941284
Five-Year Multicenter Cohort Study of Vaginal Microbiome and STIs Progression
A Five-Year Longitudinal Follow-Up Study on Vaginal Microbiome Characteristics and Their Association With Reproductive Tract STIs and Cervical Lesion Progression Based on a Multicenter Cohort
- To elucidate the long-term impact of vaginal microbiome and the dynamic trends of its characteristics across 5 years follow-up visits on the clinical outcomes of sexually transmitted infections (STIs).
- To determine the long-term effects of specific microbial infections (Up6, MH) and vaginal microbiome characteristics on the progression of STIs.
Studieoversikt
Status
Forhold
Detaljert beskrivelse
This multicenter, observational study is a 5-year longitudinal follow-up extending the CALM2004 cohort. It aims to enroll 7,574 women aged 18-60 to investigate the long-term impact of vaginal microbiome characteristics and sexually transmitted infections (STIs) on cervical lesion progression. By collecting vaginal secretions, and blood samples, the study will evaluate the 5-year cumulative incidence of CIN2+ and determine how specific microbial infections (e.g., Up6, MH) influence clinical outcomes, providing high-level evidence for cervical cancer prevention strategies.
Studietype
Registrering (Antatt)
Kontakter og plasseringer
Studiekontakt
- Navn: Muxuan Chen, Doctor
- Telefonnummer: +8613580561916
- E-post: muxuanchen@126.com
Studiesteder
-
-
Beijing Municipality
-
Beijing, Beijing Municipality, Kina
- Peking University First Hospital
-
Ta kontakt med:
- Bingbing Xiao, Doctor
-
-
Fujian
-
Fuzhou, Fujian, Kina
- Fujian Maternity and Child Health Hospital
-
-
Gansu
-
Lanzhou, Gansu, Kina
- The First Hospital of Lanzhou University
-
Ta kontakt med:
- Haitao Yu, Doctor
-
Lanzhou, Gansu, Kina
- Gansu Provincial Hospital
-
Ta kontakt med:
- Lianhua Wei, Doctor
-
-
Guangdong
-
Chaozhou, Guangdong, Kina
- Chaozhou Central Hospital
-
Ta kontakt med:
- Fen lin, Doctor
-
Foshan, Guangdong, Kina
- Guangdong Provincial Hospital of Integrated Traditional Chinese and Western Medicine
-
Ta kontakt med:
- Chaoxin Jiang, Doctor
-
Guangzhou, Guangdong, Kina
- The First Affiliated Hospital, Sun Yat-sen University
-
Ta kontakt med:
- Bin Huang, Doctor
-
Guangzhou, Guangdong, Kina
- Nanfang Hospital, Southern Medical University
-
Ta kontakt med:
- Dehua Sun, Doctor
-
Guangzhou, Guangdong, Kina
- The Fifth Affiliated Hospital of Southern Medical University
-
Ta kontakt med:
- Xiaoyan Li, Doctor
-
Guangzhou, Guangdong, Kina
- The First Affiliated Hospital of Guangzhou University of Chinese Medicine
-
Ta kontakt med:
- Yingchun Zhou, Doctor
-
Guangzhou, Guangdong, Kina
- The Fifth Affiliated Hospital of Guangzhou Medical University
-
Ta kontakt med:
- Liang Peng, Doctor
-
Guangzhou, Guangdong, Kina
- The Third Affiliated Hospital of Southern Medical University
-
Ta kontakt med:
- Xuefeng Wang, Doctor
-
Guangzhou, Guangdong, Kina
- The Third Affiliated Hospital of Guangzhou University of Chinese Medicine
-
Ta kontakt med:
- Kewei Zhao, Doctor
-
Guangzhou, Guangdong, Kina
- Zhujiang Hospital of Southern Medical University
-
Guangzhou, Guangdong, Kina
- Guangzhou Baiyun District Taihe People's Hospital
-
Huizhou, Guangdong, Kina
- Huizhou Municipal Central Hospital
-
Ta kontakt med:
- Xianjin Wu, Doctor
-
Shaoguan, Guangdong, Kina
- Yuebei People's Hospital
-
Ta kontakt med:
- Pingsen Zhao, Doctor
-
Shenzhen, Guangdong, Kina, 518028
- Shenzhen Maternity & Child Healthcare Hospital
-
Ta kontakt med:
- Yuting Dai
- Telefonnummer: 0755-82869849
-
Shenzhen, Guangdong, Kina
- Luohu District People's Hospital
-
Shenzhen, Guangdong, Kina
- Southern Medical University Shenzhen Hospital
-
Ta kontakt med:
- Hongwei Zhou, Doctor
-
Shenzhen, Guangdong, Kina
- The Seventh Affiliated Hospital, Sun Yat-sen University
-
Ta kontakt med:
- Zhaofan Luo, Doctor
-
Zhongshan, Guangdong, Kina
- Zhongshan Xiaolan People's Hospital
-
Ta kontakt med:
- Wandang Wang, Doctor
-
Zhuhai, Guangdong, Kina
- Zhuhai Maternal and Child Health Hospital
-
-
Guangxi
-
Nanning, Guangxi, Kina
- The First Affiliated Hospital of Guangxi Medical University
-
Ta kontakt med:
- Faquan Lin, Doctor
-
-
Guizhou
-
Guiyang, Guizhou, Kina
- Affiliated Hospital of Guizhou Medical University
-
Ta kontakt med:
- Fan Lu, Doctor
-
Zunyi, Guizhou, Kina
- Zunyi First People's Hospital
-
Ta kontakt med:
- Kaifeng Wu, Doctor
-
-
Hainan
-
Haikou, Hainan, Kina
- Hainan General Hospital
-
Ta kontakt med:
- Bo Wang, Doctor
-
-
Heilongjiang
-
Mudanjiang, Heilongjiang, Kina
- Hongqi Hospital Affiliated to Mudanjiang Medical University
-
Ta kontakt med:
- Chunxia Guo, Doctor
-
Qiqihar, Heilongjiang, Kina
- Qiqihar First Hospital
-
-
Henan
-
Zhengzhou, Henan, Kina
- Henan Provincial People's Hospital
-
Ta kontakt med:
- Jing Zhao, Doctor
-
-
Inner Mongolia
-
Hohhot, Inner Mongolia, Kina
- Inner Mongolia Autonomous Region Maternal and Child Health Hospital
-
Ta kontakt med:
- Jing Sha, Doctor
-
-
Jiangsu
-
Lianyungang, Jiangsu, Kina
- The Second People's Hospital of Lianyungang
-
Ta kontakt med:
- Wei Liang, Doctor
-
-
Jilin
-
Jilin City, Jilin, Kina
- Jilin City Central Hospital
-
Ta kontakt med:
- Guijie Zhang, Doctor
-
-
Liaoning
-
Shenyang, Liaoning, Kina
- The First Hospital of China Medical University
-
Ta kontakt med:
- Ruizhe Wang, Doctor
-
-
Ningxia
-
Yinchuan, Ningxia, Kina
- General Hospital of Ningxia Medical University
-
Ta kontakt med:
- Feng Li, Doctor
-
-
Qinghai
-
Xining, Qinghai, Kina
- Qinghai Red Cross Hospital
-
Ta kontakt med:
- Dengyun Ma, Doctor
-
-
Shandong
-
Jinan, Shandong, Kina
- Jinan Central Hospital
-
Ta kontakt med:
- Shuyi Han, Doctor
-
Jinan, Shandong, Kina
- Shandong Provincial Hospital
-
-
Shanghai Municipality
-
Shanghai, Shanghai Municipality, Kina
- Shanghai East Hospital, Tongji University
-
Ta kontakt med:
- Jingxin Cheng, Doctor
-
-
Shanxi
-
Changzhi, Shanxi, Kina
- Changzhi People's Hospital
-
Ta kontakt med:
- Guoxiang Zhang, Doctor
-
-
Sichuan
-
Dazhou, Sichuan, Kina
- Dazhou Integrated Traditional Chinese and Western Medicine Hospital
-
Ta kontakt med:
- Xuesu He, Doctor
-
Luzhou, Sichuan, Kina
- Affiliated Hospital of Southwest Medical University
-
Ta kontakt med:
- Jinbo Liu, Doctor
-
-
Tibet
-
Lhasa, Tibet, Kina
- Tibet Autonomous Region People's Hospital
-
-
Deltakelseskriterier
Kvalifikasjonskriterier
Alder som er kvalifisert for studier
Tar imot friske frivillige
Kjønn som er kvalifisert for studier
Prøvetakingsmetode
Studiepopulasjon
A total of 7,574 women aged 18-60 years who previously participated in the baseline of the CALM2004 multicenter cohort study will be recruited for this 5-year longitudinal follow-up. This is a multicenter study, and participants will be recruited through targeted invitations from the research team members. The study population consists of women with a broad spectrum of baseline vaginal microecological statuses and varying risks of STIs and cervical lesions.
Beskrivelse
Inclusion Criteria:
- Female aged 18 to 60 years.
- Participants who previously participated in the baseline of the CALM2004 study.
- Volunteers who are recruited through targeted invitations and consent to participate in this study.
Exclusion Criteria:
- Pregnant women.
- Received treatment for reproductive tract infections or sexually transmitted infections (STIs) within the past month.
- Used broad-spectrum antibiotics, local genital probiotics, or vaginal suppositories within the past month.
Studieplan
Hvordan er studiet utformet?
Designdetaljer
- Observasjonsmodeller: COHORT
- Tidsperspektiver: PROSPECTIVE
Kohorter og intervensjoner
Gruppe / Kohort |
|---|
|
CALM2004 Follow-up Cohort
A total of 7,574 women aged 18-60 who previously participated in the CALM2004 baseline study will be enrolled for a 5-year longitudinal follow-up. Participants will undergo comprehensive assessments including questionnaires, vaginal secretion collection for metagenomic sequencing, cervical exfoliated cells for TCT and STI nucleic acid testing, and venous blood testing. No specific interventions will be administered. |
Hva måler studien?
Primære resultatmål
Resultatmål |
Tiltaksbeskrivelse |
Tidsramme |
|---|---|---|
|
Cumulative incidence of CIN2+ at 5 years
Tidsramme: 5 years
|
The incidence rate of histologically confirmed Cervical Intraepithelial Neoplasia grade 2 or 3 (CIN2/3) or invasive cervical cancer occurring for the first time during the follow-up period, among participants who had no cervical lesions or were <CIN2 at baseline |
5 years
|
Sekundære resultatmål
Resultatmål |
Tiltaksbeskrivelse |
Tidsramme |
|---|---|---|
|
New incidence and progression rates of ASC-US+ cytological abnormalities
Tidsramme: 5 years
|
ASC-US+ new incidence: First occurrence of ASC-US or higher cytological abnormality during follow-up in participants with normal baseline cytology. ASC-US+ progression: First occurrence of LSIL/HSIL or higher cytological abnormality during follow-up in participants with baseline ASC-US. Cytology is evaluated according to the Bethesda System for Reporting Cervical Cytology. |
5 years
|
Andre resultatmål
Resultatmål |
Tiltaksbeskrivelse |
Tidsramme |
|---|---|---|
|
HPV and STI incidence, clearance, and persistent/recurrent infection rates
Tidsramme: 5 years
|
HPV new infection: baseline negative, follow-up positive; HPV clearance: baseline positive, follow-up negative; HPV persistent infection: same genotype positive at both baseline and follow-up. STI new infection: baseline negative, follow-up positive; STI clearance: baseline positive, follow-up same genotype negative; STI recurrent infection: same genotype positive at both baseline and follow-up. |
5 years
|
Samarbeidspartnere og etterforskere
Samarbeidspartnere
Etterforskere
- Studiestol: Hongwei Zhou, Doctor, Shenzhen Hospital of Southern Medical University
Studierekorddatoer
Studer hoveddatoer
Studiestart (Antatt)
Primær fullføring (Antatt)
Studiet fullført (Antatt)
Datoer for studieregistrering
Først innsendt
Først innsendt som oppfylte QC-kriteriene
Først lagt ut (Faktiske)
Oppdateringer av studieposter
Sist oppdatering lagt ut (Faktiske)
Siste oppdatering sendt inn som oppfylte QC-kriteriene
Sist bekreftet
Mer informasjon
Begreper knyttet til denne studien
Ytterligere relevante MeSH-vilkår
- Urogenitale sykdommer
- Kjønnssykdommer
- Patologiske prosesser
- Sykdomsattributter
- Infeksjoner
- Virussykdommer
- Smittsomme sykdommer
- Seksuelt overførbare sykdommer, virale
- DNA-virusinfeksjoner
- Tumorvirusinfeksjoner
- Patologiske tilstander, tegn og symptomer
- Seksuelt overførbare sykdommer
- Papillomavirusinfeksjoner
Andre studie-ID-numre
- CALM2004-5
Legemiddel- og utstyrsinformasjon, studiedokumenter
Studerer et amerikansk FDA-regulert medikamentprodukt
Studerer et amerikansk FDA-regulert enhetsprodukt
Denne informasjonen ble hentet direkte fra nettstedet clinicaltrials.gov uten noen endringer. Hvis du har noen forespørsler om å endre, fjerne eller oppdatere studiedetaljene dine, vennligst kontakt register@clinicaltrials.gov. Så snart en endring er implementert på clinicaltrials.gov, vil denne også bli oppdatert automatisk på nettstedet vårt. .